Colgate-Palmolive (CL), with a
new 2030 plan and 2026 outlook, has made it one of the top low volatility blue chip stocks to invest in.
Deutsche Bank and
UBS have reiterated its lucrative long-term prospects by updating its analyst rating to 'Buy', indicating strong position despite recent price target adjustments. The company's governance proposals could significantly boost its standing in the market. Various investment entities, such as Allspring Global Investments and Cidel Asset Management, hold substantial stock positions. A noteworthy change in
leadership transition is slated for 2026, which could impact Colgate's future trajectory. Ongoing
legal scrutiny and governance pressure may also influence the bull case for Colgate's brand strategy. With its international sales shining, RBC rates the stock as
Outperform, keeping long-term growth into focus. Its
quarterly dividend increase and largely conservative 2026 guidance maintain investor confidence. However, high oil prices and macro risks could yield headwinds, necessitating a balanced risk/reward approach.
Colgate-Palmolive Company CL News Analytics from Sun, 13 Jul 2025 07:00:00 GMT to Sat, 11 Apr 2026 19:13:56 GMT -
Rating 7
- Innovation -5
- Information 8
- Rumor -1
